Plasma tau protein and Aβ42 level as markers of cognitive impairment in patients with Parkinson’s disease

Advances in Clinical and Experimental Medicine, 1(29), p. 115-121, 2020

Journal article published in 2020 by Justyna Chojdak-Łukasiewicz

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload